IP Library Granted Patent US 7,960,602
Granted Patent B2
US 7,960,602 · App. 11/323,069 · Granted Jun 14, 2011

Compositions and processes for accelerated wound healing using novel fibrous webbings

Assignee: Bayer Innovation GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,960,602
App. No.
11/323,069
Granted
Jun 14, 2011
Kind
B2
Abstract

The present invention provides a multilayer bandage, having a webbing for contacting a wound and a first membrane that has at least one water-insoluble polymer and is water-impervious. The present invention further provides methods for making the multilayer bandage, methods of using the multilayer bandage for accelerated wound healing, and kits having compositions of the present invention.

Claims (48)

1. A wound healing multilayer bandage comprising:

(i) a webbing for placement in direct contact with a wound having a periphery; and

(ii) a first membrane comprising at least one water-insoluble polymer;

wherein the webbing has a biologically degradable or a biologically resorbable fiber structure;

wherein the webbing is a spun-bonded webbing;

wherein the webbing comprises at least one partially or completely hydrolytically condensed silicon compound;

wherein the first membrane is water-impervious or semi-permeable;

wherein the first membrane either (a) further comprises an adhesive portion wherein the adhesive portion adheres to skin tissue at the wound periphery or (b) does not comprise an adhesive portion and bonds with an adhesive which is applied to the skin tissue at the wound periphery, wherein the first membrane is configured to seal the wound off from a surrounding environment when the first membrane is adhered to the skin tissue at the wound periphery or bonded to an adhesive which is applied to the skin tissue at the wound periphery; and

wherein either no bond or a loose, frangible adhesive bond exists between the first membrane and the webbing.

2. The multilayer bandage according to claim 1 , wherein the water-insoluble polymer is selected from the group consisting of polypropylene, polyvinylchloride and polyurethane.

3. The multilayer bandage according to claim 1 , wherein the first membrane is a self-adhesive hydropolymer.

4. The multilayer bandage according to claim 1 , wherein the webbing is a fibrous webbing.

5. The multilayer bandage according to claim 1 , wherein the silicon compound comprises a monomer of the formula SiX 4 wherein residues X 1 , X 2 , X 3 , and X 4 are independently selected from the group consisting of hydroxyl, hydrogen, halogen, amino, alkoxy, alkyloxy, alkylcarbonyl and alkoxycarbonyl.

6. The multilayer bandage according to claim 1 , wherein the silicon compound comprises a monomer of the formula SiX 4 wherein residues X 1 , X 2 , X 3 , and X 4 are derived from an alkyl and can be interrupted by an oxygen atom, a sulfur atom or an amino group and wherein residues X 1 , X 2 , X 3 , and X 4 are identical or different.

7. The multilayer bandage according to claim 6 , wherein residues X 1 , X 2 , X 3 , and X 4 are ethyl.

8. The multilayer bandage according to claim 7 , wherein the webbing comprises a morphogenic factor selected from the group consisting of a steroid, a cytokine, an interleukin, a bone morphogenetic protein, an antibody, TNF-α, TGF-(β½, IGF, PDGF, and EGF.

9. The multilayer bandage according to claim 1 , wherein the webbing comprises an organic compound selected from the group consisting of a nucleotide, an amino acid and polymers thereof.

10. A wound healing multilayer bandage comprising:

(i) a webbing for placement in direct contact with a wound having a periphery; and

(ii) a first membrane comprising at least one water-insoluble polymer;

wherein the webbing has a biologically degradable or a biologically resorbable fiber structure;

wherein the webbing is a spun-bonded webbing;

wherein the webbing comprises at least one partially or completely hydrolytically condensed silicon compound;

wherein the first membrane is water-impervious;

wherein the first membrane either (a) further comprises an adhesive portion wherein the adhesive portion adheres to skin tissue at the wound periphery or (b) does not comprise an adhesive portion and bonds with an adhesive which is applied to the skin tissue at the wound periphery, wherein the first membrane is configured to seal the wound off from a surrounding environment when the first membrane is adhered to the skin tissue at the wound periphery or bonded to an adhesive which is applied to the skin tissue at the wound periphery; and

wherein either no bond or a loose, frangible adhesive bond exists between the first membrane and the webbing; and

(iii) a second membrane comprising at least one water-soluble polymer;

wherein the second membrane is disposed between the first membrane and the webbing.

11. The multilayer bandage according to claim 10 , wherein the water-soluble polymer is carboxymethylcellulose.

12. The multilayer bandage according to claim 10 , wherein a bond exists between the second membrane and the webbing and wherein the bond is a loose, frangible adhesive bond.

13. The multilayer bandage according to claim 10 , wherein no adhesive bond exists between the second membrane and the webbing.

14. The multilayer bandage according to claim 10 , wherein a bond exists between the first membrane and the second membrane and wherein the bond is a loose, frangible adhesive bond or a stable, non-frangible adhesive bond.

15. A wound healing multilayer bandage comprising:

(i) a webbing for placement in direct contact with a wound having a periphery; and

(ii) a first membrane comprising at least one water-insoluble polymer;

wherein the webbing has a biologically degradable or a biologically resorbable fiber structure;

wherein the webbing is a spun-bonded webbing;

wherein the webbing comprises at least one partially or completely hydrolytically condensed silicon compound;

wherein the first membrane is water-impervious;

wherein the first membrane either (a) further comprises an adhesive portion wherein the adhesive portion adheres to skin tissue at the wound periphery or (b) does not comprise an adhesive portion and bonds with an adhesive which is applied to the skin tissue at the wound periphery, wherein the first membrane is configured to seal the wound off from a surrounding environment when the first membrane is adhered to the skin tissue at the wound periphery or bonded to an adhesive which is applied to the skin tissue at the wound periphery; and

wherein either no bond or a loose, frangible adhesive bond exists between the first membrane and the webbing; and

(iii) a dressing selected from the group consisting of an alginate, a collagen sponge, a polyurethane foam, a polyurethane foam pad, a hydrocolloid, a hydrogel and a hydropolymer, and wherein the dressing is disposed between the webbing and the first membrane.

16. The multilayer bandage according to claim 15 , wherein a bond exists between the dressing and the webbing and wherein the bond is a loose, frangible adhesive bond.

17. The multilayer bandage according to claim 15 , wherein no adhesive bond exists between the dressing and the webbing.

18. The multilayer bandage according to claim 15 , wherein a bond exists between the dressing and the first membrane and wherein the bond is either a loose, frangible adhesive bond or a stable, non-frangible adhesive bond.

19. A method for treating a wound having a periphery, the method comprising:

placing a webbing in direct contact with a wound, wherein the webbing is spun-bonded webbing and has a biologically degradable or a biologically resorbable fiber structure, wherein the webbing comprises at least one partially or completely hydrolytically condensed silicon compound; and

applying a first membrane onto a top side of the webbing, wherein the top side of the webbing is located opposite to the wound, wherein the first membrane is water-impervious or semi-permeable such that moisture is prevented from evaporating outwardly from the wound through the first membrane, wherein the first membrane comprises at least one water-insoluble polymer, wherein the first membrane either (a) further comprises an adhesive portion wherein the adhesive portion adheres to skin tissue at the periphery of the wound or (b) does not comprise an adhesive portion and bonds with an adhesive which is applied to the skin tissue at the periphery of the wound, and further wherein either no bond or a loose, frangible adhesive bond exists between the first membrane and the webbing.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2015
From: SYNECON (SUZHOU) CO., LTD.
To: JIANGSU SYNECOUN MEDICAL TECHNOLOGY CO., LTD.
Reel/Frame 036415/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2015
From: BAYER INNOVATION GMBH
To: SYNECON (SUZHOU) CO., LTD.
Reel/Frame 035865/0758 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2006
From: THIERAUF, AXEL; HAISCH, ANDREAS; BAECKER, IWER
To: BAYER INNOVATION GMBH
Reel/Frame 017703/0971 →
Priority Claims (1)
DE 10 2004 063 599 · Dec 30, 2004 · national
Continuity (2)
Provisional Application 60640896 · Dec 30, 2004
Related Publication 20060161089A1 · Jul 20, 2006